ctrl K

Belite Bio Inc (BLTE)

NASDAQ: BLTE · Real-Time Price · USD

61.34

-0.14 (-0.23%)

At close: May 01, 2025, 3:59 PM

61.90

0.91%

After-hours: May 01, 2025, 04:05 PM EDT

Belite Bio Inc Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	449K	399K	198K	30K	17K
Gross Profit	-449K	-399K	-198K	-30K	-17K
Operating Income	-40M	-31.67M	-12.82M	-9.8M	-5.74M
Interest Income	3.74M	74K	23K	5K	12K
Pretax Income	-36.14M	-31.62M	-12.65M	-9.67M	-5.75M
Net Income	-36.14M	-31.63M	-12.47M	-9.79M	-5.75M
Selling & General & Admin	9.61M	6.82M	3.95M	2.38M	2.06M
Research & Development	29.94M	24.84M	8.87M	7.42M	3.69M
Other Expenses	n/a	n/a	166K	126K	n/a
Operating Expenses	39.55M	31.67M	12.82M	9.8M	5.74M
Interest Expense	20K	25K	16K	n/a	21K
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	-40M	31.67M	12.82M	9.8M	5.74M
Income Tax Expense	6K	9K	-173K	126K	1K
Shares Outstanding (Basic)	30.54M	26.59M	19.98M	24.1M	24.1M
Shares Outstanding (Diluted)	30.54M	26.59M	19.98M	24.1M	24.1M
EPS (Basic)	-1.18	-1.19	-0.62	-0.41	-0.24
EPS (Diluted)	-1.18	-1.19	-0.62	-0.41	-0.24
EBITDA	-35.67M	-31.53M	-12.43M	-9.64M	-5.71M
EBIT	-36.12M	-31.67M	-12.63M	-9.67M	-5.73M
Depreciation & Amortization	449K	139K	198K	30K	17K